Josh Enomoto

Josh Enomoto

InvestorPlace Contributor

Brokering multi-million-dollar deals with some of the world’s biggest companies and providing in-depth marketing analyses, Josh Enomoto takes his firsthand knowledge of the corporate boardroom and delivers them across several media outlets. In addition to his work at InvestorPlace, Josh contributes content for Benzinga, TipRanks, EmergingGrowth and Blockster. He is also a guest expert at CGTN America.

While leaving no stone unturned regarding sector coverage, Josh has written extensively about cryptocurrencies. You can follow him on Blockster, a crypto-centric social media platform and on LinkedIn.

Recent Articles

Second Sight Medical Products Is No Short Squeeze

By Josh Enomoto, InvestorPlace Contributor

EYES stock jumped higher off a very encouraging FDA approval but now is the time to apply a little more scrutiny to the Second Sight Medical investment.

Common Sense Says Stay Clear of Foley Trasimene Acquisition Corp. II

By Josh Enomoto, InvestorPlace Contributor

BFT stock attracts plenty of attention thanks to the announced Paysafe merger but recent trading suggests some headwinds are brewing.

7 High-Flying Stocks That Could Crash 20% or Even More

By Josh Enomoto, InvestorPlace Contributor

If nothing happens – and that’s the hope – this article will be nothing but a good laugh. However, astute investors should at least know about these stocks that could crash.

Gores Holdings VI Is Hot but Do Your Due Diligence

By Josh Enomoto, InvestorPlace Contributor

As one of the hottest SPACs, GHVI stock brings a relevant technology to the table. But you’ll still want to assess the broader economic environment before making your final decision.

Opendoor Technologies May Be Your Ultimate Litmus Test

By Josh Enomoto, InvestorPlace Contributor

Both on the fundamentals and the technicals, OPEN stock seems like it can move in either direction. Essentially, this makes Opendoor Technologies a litmus test for one’s belief in the economic recovery narrative.

Load More